These findings are consistent with current evidence that FABP3 can be considered to be a prognostic marker for arrhythmia, heart failure, AMI, and pulmonary embolism, all of which are associated with poor clinical outcomes 31,32-34, and that inflammation induced by FABP3 may lead to CVD 15. This evidence concerns the gene FABP3 and cardiac arrhythmia.